6May - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe fundamentals of running a pharmaceutical enterprise revolve around the discovery, development, manufacturing, and marketing of new drugs. While these four activities define the progress of the company, the task of overseeing each of them individually can become difficult as the business expands. Drug discovery and marketing are the most vital for the growth of a large pharmaceutical enterprise, hence employing a contract manufacturing organization (CMO) to manage the development and manufacturing of a drug significantly improves revenue generation and other bottomline operations. By the end of 2018, the CMO industry was valued at 149.8 billion dollars, and is projected to expand at a CAGR of seven percent from 2019 to 2026. And the biggest factor influencing a major drug company's shift toward adopting CMOs lies in the growing need for cutting-edge processes and production technologies, which have proven to be highly effective in meeting regulatory requirements consistently. With the outsourcing of manufacturing and development operations, pharmaceutical companies are empowered to delve deeper into their discovery and outreach to bolster sales, remaining relevant and competitive in the marketplace.Recognizing the CMOs that offer such innovative solutions and services, Pharma Tech Outlook brings to you this edition on CMOs. This edition also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the most cost-effective and efficient contract manufacturing services according to your requirements.Let us know your thoughts!The New Dawn of Pharmaceutical OutsourcingCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 19 - 2020, Vol 06 - Issue 07 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >